Literature DB >> 14582146

Candidate gene analysis of the human metabotropic glutamate receptor type 4 (GRM4) in patients with juvenile myoclonic epilepsy.

Claudia Izzi1, Alessandro Barbon, Mohammad Reza Toliat, Armin Heils, Christian Becker, Peter Nürnberg, Thomas Sander, Sergio Barlati.   

Abstract

Hereditary factors play a major role in the genetically complex etiology of juvenile myoclonic epilepsy (JME). Linkage studies in families of JME probands suggest a susceptibility locus (EJM1) for idiopathic generalized epilepsy (IGE) in the chromosomal region 6p21.3 near the HLA region. The gene encoding the metabotropic glutamate receptor type 4 (GRM4) has been localized within the EJM1-region and represents a high-ranking candidate gene. Therefore, we have sequenced the coding regions and regulatory GRM4 sequences in 20 IGE probands who were derived from families of JME probands providing positive linkage evidence to the HLA-DQ locus. Our mutation analysis detected three synonymous exonic single nucleotide polymorphisms (SNP; exon-7: c.1455T > C, exon-8: c.2002A > G, exon-10: c.2733C > T), one SNP in the 3'-untranslated region (c.2890A > G), and two intronic SNPs (intron-3: IVS3 + 2732A > G, intron-7: IVS7 + 39C > T). None of the identified SNPs was likely to affect receptor function or gene expression. The population-based association study did not show significant differences in the allele and genotype frequencies of the common c.1455T > C SNP between 144 German JME probands and 144 healthy population controls (P > 0.84). Likewise, the family-based transmission disequilibrium test did not indicate a preferential transmission of exon-7 SNP alleles in 31 informative parent-child transmissions (P = 0.86). Our results provide no evidence that genetic variation of the GRM4 gene confers susceptibility to JME-related IGE syndromes. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14582146     DOI: 10.1002/ajmg.b.20024

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  5 in total

1.  Association of the GRM4 gene variants with juvenile myoclonic epilepsy in an Indian population.

Authors:  Rashmi Parihar; Rohit Mishra; Sanjeev Kumar Singh; Sita Jayalakshmi; Man Mohan Mehndiratta; Subramaniam Ganesh
Journal:  J Genet       Date:  2014-04       Impact factor: 1.166

2.  Neurochemical and behavioral features in genetic absence epilepsy and in acutely induced absence seizures.

Authors:  A S Bazyan; G van Luijtelaar
Journal:  ISRN Neurol       Date:  2013-05-07

Review 3.  Metabotropic glutamate receptors: from the workbench to the bedside.

Authors:  F Nicoletti; J Bockaert; G L Collingridge; P J Conn; F Ferraguti; D D Schoepp; J T Wroblewski; J P Pin
Journal:  Neuropharmacology       Date:  2010-10-29       Impact factor: 5.250

Review 4.  Genetic susceptibility in Juvenile Myoclonic Epilepsy: Systematic review of genetic association studies.

Authors:  Bruna Priscila Dos Santos; Chiara Rachel Maciel Marinho; Thalita Ewellyn Batista Sales Marques; Layanne Kelly Gomes Angelo; Maísa Vieira da Silva Malta; Marcelo Duzzioni; Olagide Wagner de Castro; João Pereira Leite; Fabiano Timbó Barbosa; Daniel Leite Góes Gitaí
Journal:  PLoS One       Date:  2017-06-21       Impact factor: 3.240

5.  Effects of GRM4, SCN2A and SCN3B polymorphisms on antiepileptic drugs responsiveness and epilepsy susceptibility.

Authors:  Laith N Al-Eitan; Islam M Al-Dalalah; Hanan A Aljamal
Journal:  Saudi Pharm J       Date:  2019-04-24       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.